Tyr-W-MIF-1 attenuates down-regulation of opiate receptors in SH-SY5Y human neuroblastoma cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 2, 1998, Pages 611-617

  Harrison, Laura M ^a   Kastin, Abba J ^a   Zadina, James E ^a,b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MORPHINE; MU OPIATE RECEPTOR; OPIATE AGONIST; OPIATE RECEPTOR; PEPTIDE DERIVATIVE; TYROSYLPROLYLTRYPTOPHYLGLYCINAMIDE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

CULTURE MEDIA; DOWN-REGULATION; ENDORPHINS; ENKEPHALIN, METHIONINE; HUMANS; MORPHINE; MSH RELEASE-INHIBITING HORMONE; NALOXONE; NEUROBLASTOMA; NEURONS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0031884137     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. 3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma-glioma hybrid cell line (NG 108-15). Proc Natl Acad Sci USA 82:2543-2547.
2. Allard S, Geoffre S, Legendre P, Vincent JD and Simonnet G (1989) Characterization of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide: a binding study. Brain Res 500:169-176.
3. Arden JR, Segredo V, Wang Z, Lameh J and Sadee W (1995) Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. J Neurochem 65:1636-1645.
4. Baumhaker Y, Gafni M, Keren O and Same Y (1993) Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells. Mol Pharmacol 44:461-467.
5. Bhargava H and Gulati A (1990) Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats. Eur J Pharmacol 190:305-311.
6. Carter BD and Medzhiradsky F (1993) Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells. Mol Pharmacol 43:465-473.
7. Chang K-J, Eckel RW and Blanchard SG (1982) Opioid peptides induce reduction of enkephalin receptors in cultured neuroblastoma cells. Nature 296:446-448.
8. 2 (Tyr-W-MIF-1). Peptides 13:623-631.
9. Erchegyi J, Zadina JE, Qui X-D, Kersh D, Ge L-J, Brown MM and Kastin AJ (1993) Structure-activity relationships of analogs of the endogenous brain peptides Tyr-MIF-1 and Tyr-W-MIF-1. Pept Res 6:31-37.
10. Galina ZH and Kastin AJ (1987) Tyr-MIF-1 attenuates antinociceptive responses induced by three models of stress-analgesia. Br J Pharmacol 90:669-674.
11. 2-adrenoceptors. Eur J Pharmacol 298:235-239.
12. 1-opioid receptor antagonist. Eur J Pharmacol 316:33-38.
13. Hackler L, Kastin AJ, Erchegyi J and Zadina JE (1993) Isolation of Tyr-W-MIF-1 from bovine hypothalami. Neuropeptides 24:159-164.
14. 5]enkephalin. Eur J Pharmacol 165:1-10.
15. Hollt V, Dum J, Blasig J, Schubert P and Herz A (1975) Comparison at in vivo and in vitro parameters of receptor binding in naive and tolerant/dependent rats. Life Sci 16:1823-1828.
16. Horvath A and Kastin AJ (1989) Isolation of tyrosine-melanocyte-stimulating hormone release-inhibiting factor-1 from bovine brain tissue. J Biol Chem 264:2175-2179.
17. 2) in human brain cortex. Int J Pept Protein Res 36:281-284.
18. Jiang Q, Mosberg HI and Porreca F (1990) Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse. J Pharmacol Exp Ther 254:683-689.
19. Kastin AJ, Olson RD, Ehrensing RH, Berzas MC, Schally AV and Coy DH (1979) MIF-1's differential actions as an opiate antagonist. Pharmacol Biochem Behav 11:721-723.
20. Kastin AJ, Stephens E, Ehrensing RH and Fischman AJ (1984) Tyr-MIF-1 acts as an opiate antagonist in the tail-flick test. Pharmacol Biochem Behav 21:937-941.
21. Kastin AJ, Hahn K, Banks WA and Zadina J (1994) Delayed degradation of Tyr-MIF-1 in neonatal rat plasma. Peptides 8:1561-1563.
22. Keith DE, Murray SR, Zaki PA, Chu PC, Lisain DV, Kang L, Evans CJ and Von Zastrow M (1996) Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 271:19021-19024.
23. Mee WA and Streaty RA (1974) Narcotic receptor sites in morphine-dependent rats. Nature 248:61-63.
24. Lake JR, Hammond MV, Shaddox RC, Hunsicker LM, Yang HY-T and Malin D (1991) IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat. Neurosci Lett 132:29-32.
25. Law PY, Hom DS and Loh HH (1982) Loss of receptor activity in neuroblastoma x glioma NG108-15 hybrid cells after chronic opiate treatment: a multiple step process. Mol Pharmacol 22:1-4.
26. Law PY, Hom DS and Loh HH (1983) Opiate receptor down-regulation and desensitization in neuroblastoma x glioma NG108-15 hybrid cells are two separate cellular adaptation processes. Mol Pharmacol 24:413-424.
27. Lowry OH, Rosebrough NJ, Fair AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
28. 2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat. Peptides 11:277-280.
29. 2-like mammalian octapeptide: Possible role in opiate dependence and abstinence. Peptides 11:969-972.
30. Malin DR, Zadina JE, Lake JR, Rogillio RB, Leyva JE, Benson TM, Corriere LS, Handunge BP and Kastin AJ (1993) Tyr-MIF-1 precipitates abstinence syndrome in morphine-dependent rats. Brain Res 610:169-171.
31. 2b receptors. Peptides 15:401-404.
32. Rothman RB (1992) A review of the role of anti-opioid peptides in morphine tolerance and dependence. Synapse 12:129-138.
33. Smith AP, Law PY and Loh HH (1988) Role of opioid receptors to narcotic dependence/tolerance, in The Opiate Receptors (Pasternak G, ed) pp 441-485, Humana Press, Clifton, NJ.
34. Tao P-L, Law P-Y and Loh HH (1987) Decrease to delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment. J Pharmacol Kxp Ther 240:809-816.
35. Tao P-L, Lee H-Y, Chaog L-R and Loh HH (1990) Decease in mu-opioid receptor binding capacity in rat brain after chronic PL017 treatment. Brain Res 626:270-275.
36. 5]enkephalin on rat brain opioid receptors. Eur J Pharmacol 201:209-214.
37. Tempel A, Habas J, Paredes W and Barr GA (1988) Morphine-induced down-regulation of mu-opioid receptors in neonatal rat brain. Dev Brain Res 41:129-133.
38. Werting L, McMahon PN and Cox BM (1989) Selective changes in mu opioid receptor properties induced by chronic morphine exposure. Proc Natl Acad Sci USA 86:6393-6397.
39. Yang HY-T, Fratta W, Majane EA and Costa E (1985) Isolation, sequencing, synthesis and pharmacological characterization of two brain neuropeptides that modulate the actions of morphine. Proc Natl Acad Sci USA 82:7757-7761.
40. Zadina JE, Chang SL, Ge L-J, Kastin AJ and Harlan RE (1990) Down-regulation of mu opiate receptors by morphine and presence of Tyr-MIF-1 binding sites in SH-SY5Y human neuroblastoma cells, in New Leads in Opioid Research (van Ree JM, Mulder AH, Wiegant VM and van Wimersma Greidanus TB eds) pp 151-153, Excerpta Medica, New York.
41. Zadina JE, Chang SL, Ge L-J and Kastin AJ (1991) Naloxone-reversible inhibition of cyclic AMP production by Tyr-MIF-1 in SH-SY5Y human neuroblastoma cells. Soc Neurosci Abstr 17:811.
42. Zadina JE, Kastin AJ, Kersh D and Wyatt A (1992) Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum. Life Sci 51:869-885.
43. Zadina JE, Chang S-L, Ge L-J and Kastin AJ (1993a) Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells. J Pharmacol Exp Ther 265:254-262.
44. 2). Neurosci Lett 155:220-222.
45. Zadina JE, Harrison LM, Ge L-J, Kastin AJ and Chang SL (1994a) Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells. J Pharmacol Exp Ther 270:1086-1096.
46. Zadina JE, Kastin AJ, Ge L-J and Chang SL (1994b) Novel peptides and mechanisms of opiate tolerance. Regul Pept Suppl 1:S195-S196.
47. Zadina JE, Kastin AJ, Ge L-J and Hackler L (1994c) Mu, delta and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments and two potent analogs. Life Sci 55:PL461-PL466.
48. Zadina JE, Kastin AJ, Harrison LM, Ge L-J and Chang SL (1995) Opiate receptor changes after chronic exposure to agonists and antagonists. Ann NY Acad Sci 257:353-361.
49. 2 opiate receptors. Neurosci Lett 215:65-69.